Chiral nanomaterials as vaccine adjuvants: a new horizon in immunotherapy
Nanoscale · 2025
DOI: 10.1039/d4nr03542a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2025. Verfasst von Kaixuan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, China. hongshuang.wa…. Hauptthemen laut MEDLINE: Nanostructures, Immunotherapy, Neoplasms, Adjuvants, Vaccine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Chiral nanomaterials are emerging as a promising class of vaccine adjuvants with the potential to significantly enhance vaccine efficacy, especially in the context of cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, China. hongshuang.wang@ciac.ac.cn.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, 230026, China.
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Wang, K., Wang, H., & Wang, X. (2025). Chiral nanomaterials as vaccine adjuvants: a new horizon in immunotherapy. Nanoscale. https://doi.org/10.1039/d4nr03542a
Vancouver
Wang K, Wang H, Wang X. Chiral nanomaterials as vaccine adjuvants: a new horizon in immunotherapy. Nanoscale. 2025. doi:10.1039/d4nr03542a
BibTeX
@article{Wang2025,
author = {Wang, Kaixuan and Wang, Hongshuang and Wang, Xiaohui},
title = {Chiral nanomaterials as vaccine adjuvants: a new horizon in immunotherapy},
journal = {Nanoscale},
year = {2025},
doi = {10.1039/d4nr03542a}
}
EUVIMED